JAAPA CME Post-Test November 2024
Novel Gene Therapies for Sickle Cell Disease, Duchenne Muscular Dystrophy, and Hemophilia A | Polycystic Ovary Syndrome: Fertility, Prenatal Care, Pregnancy, and Postpartum Care
Novel Gene Therapies for Sickle Cell Disease, Duchenne Muscular Dystrophy, and Hemophilia A | Polycystic Ovary Syndrome: Fertility, Prenatal Care, Pregnancy, and Postpartum Care
This presentation is intended for practicing PAs who want to learn more about the overlap between genetics and autism spectrum disorder. The goal is to help PAs “think genetically” when…
Genetic testing is becoming more affordable and more frequently covered by insurance, yet to many healthcare providers, it is a mystery. This presentation will lay out genetic and genomic testing…
Learn more about utilizing pharmacogenetic (PGx) testing before prescribing medications to patients. PGx testing has the potential to improve outcomes for patients in multiple areas of medicine. Current guidelines for…
This presentation will discuss gene-drug pairs relevant in cardiology, describe how PGx variation affects the pharmacokinetics and pharmacodynamics of cardiovascular agents, and review seminal clinical trial data impacting PGx implementation…
This presentation focuses on how to implement genetics and genomic medicine into the primary care setting. PAs will learn key clinical characteristics of rare genetic diseases and how to identify…
JAAPA CME post-tests are available in AAPA’s monthly clinical journal or online.